The U.S. Food and Drug Administration announced manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning on the risk of heart failure, a condition that occurs when the heart does not adequately pump blood. The information will be included in the form of a "boxed" warning-FDA's strongest form of a warning. [click link for full article]
More...